StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)

Close on Nov 18, 2026Market cap $106.09MP/E –Yield –

Lexaria Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lexaria Bioscience's price to book ratio was 24.3× on Nov 11, 2026, against 107.0× a year earlier. Over the last 5 years it ranged from 13.1× to 150.0×, with a median of 42.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202624.3×−36.3
2025Dec 31, 202560.5×−16.1
2024Dec 31, 202476.7×+26.8
2023Dec 29, 202349.8×+22.2
2022Dec 30, 202227.6×+1.1
2021Dec 31, 202126.5×−109.2
2020Dec 31, 2020135.7×−45.8
2019Dec 31, 2019181.5×−259.7
2018Dec 31, 2018441.2×+139.1
2017Nov 30, 2017302.1×–

More Lexaria Bioscience figures

See a number that looks wrong?